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ABSTRACT
Hepatocellular carcinoma (HCC) is frequently complicated by the occurrence 
of intrahepatic and extrahepatic metastases, leading to poor prognosis. To improve 
the prognosis for HCC patients, there is an urgent need to understand the molecular 
mechanisms of metastasis in HCC. Since protein Serine/Threonine phosphorylation 
emerges to be an important posttranslational modification critical in signaling 
process associated with cell proliferation, survival and metastasis, we employed a 
pair of primary tumor-derived and corresponding lung-metastatic counterparts (PLC/
PRF/5-PT and PLC/PRF/5-LM) and aimed to identify these changes using CelluSpot™ 
Serine/Threonine kinase peptide array. Upon analysis, we found phosphorylated level 
of nucleophosmin (NPM) at Threonine 234/237 (p-NPM-Thr234/237) had remarkably 
high level in metastatic HCC cells (PLC-LM) than the corresponding primary HCC 
cell line (PLC-PT). Similar observation was observed in another match primary and 
their metastatic counterparts (MHCC-97L and MHCC-97H). By immunohistochemical 
staining, p-NPM-Thr234/237 was consistently found to be preferentially expressed in 
metastatic HCCs when compared with primary HCC in 28 HCC cases (p < 0.0001). By 
overexpressing Flag-tagged NPM and its phosphorylation site mutant (Thr234/237A) 
into low p-NPM-Thr234/237 expressing cells (Hep3B and Huh7) using a lentiviral based 
approach, we demonstrated that p-NPM-Thr234/237 is critical in invasion and migration 
of HCC cells, and this effect was mediated by cyclin-dependent kinase 1 (CDK1). Wild-
type NPM was found to physically interact with a metastatic gene, ROCK2, and defective 
in Thr234/237 phosphorylation decreased its binding affinity, resulting in decrease in 
ROCK2 mediated signaling pathway. Identification of CDK1/p-NPM/ROCK2 signaling 
pathway provides a novel target for molecular therapy against HCC metastasis.
INTRODUCTION
Hepatocellular carcinoma (HCC) is the fifth most 
common malignancy worldwide and is the second most 
fatal cancer in Southeast Asia and Hong Kong [1]. HCC 
is frequently complicated by occurrence of intrahepatic 
and extrahepatic metastases even after surgical resection, 
thereby leading to poor prognosis. To improve the 
prognosis of HCC patients, there is an urgent need to 
understand the molecular mechanism of metastasis in HCC. 
Metastasis is a complicated process involving activation 
of multiple kinase cascades. Despite the recent advances 
in biomedical technologies, the molecular mechanism 
underlying cancer metastasis remains largely unclear.
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As a continual pursuit in search of molecular 
mechanism of HCC metastasis, we employed a pair of 
primary and its corresponding metastatic lung counterparts 
(PLC/PRF/5-PT and PLC/PRF/5-LM) by orthotropic 
injection of parental PLC/PRF/5 cell line into the liver of 
the SCID mice. These two matched HCC cell lines share 
the same genetic background but differ in invasive ability 
which was evidenced by wound healing and cell invasion 
assays. These two cell lines provide an indispensable 
tool to study HCC metastasis. Since protein Serine/
Threonine phosphorylation emerges to be an important 
posttranslational modification critical in signaling process 
associated with cell proliferation, survival and metastasis 
[2], we aimed to identify its phosphorylated substrate and 
related pathways which is critical in HCC metastasis. 
Using CelluSpot™ Serine/Threonine kinase peptide array 
analysis, we compared the phosphorylation profiling of 
the two matched HCC cell lines and found phosphorylated 
level of nucleophosmin (NPM) at Threonine 234/237 
(p-NPM-Thr234/237) had remarkably high level in metastatic 
HCC cells (PLC-LM) than the corresponding primary 
HCC cell line (PLC-PT).
Nucleophosmin (NPM), also known as B23, 
and located on chromosome 5q35, is a protein of 35–
40 KD was originally identified as a non-ribosomal 
nucleolar phosphoprotein found at high levels in the 
granular regions of the nucleolus, and shuttles between 
the nucleus and cytoplasm during the cell cycle [3]. 
NPM has been implicated in multiple cellular functions 
including ribosomal protein assembly and transport [3], 
centrosome duplication [4], and cell cycle progression 
[5] and programmed cell death [6] by direct or indirect 
mechanism. Although an elevated level of NPM is often 
found in certain types of carcinomas including HCC [7]; 
and has been proposed to be a marker for gastric, colon, 
ovarian and prostate cancer [3, 6, 8], its oncogenic role is 
far from fully understood.
Protein phosphorylation and dephosphorylation 
have been long known to be involved in regulating 
diverse physiological and pathological processes. NPM 
exists in cells as a phosphor-protein containing multiple 
phosphorylation sites [9]. Phosphorylation of NPM at 
several sites has been previously reported by several 
different kinases including casein kinase II (CKII), 
nuclear kinase II, polo-like kinase (Plk) and cdc type 
kinases (CDK1/cyclin B, CDK2/cyclin E, and CDK2/
cyclin A) during mitotic regulation and centrosome 
duplication [10, 11]. Accumulating evidence has been 
shown that phosphorylation of NPM has intimately linked 
to its proliferative effect and played a regulatory role 
in cell cycle progression. Recent studies demonstrated 
that deregulated phosphorylation at certain sites (Ser10 
and Ser70) of NPM enhanced cell transformation and 
leukemic blasts in NOD/SCID mice [11]. However, there 
are no reports showing phosphorylation events on NPM in 
pathogenesis of solid carcinoma.
In this study, we found that CDK1 mediated p-NPM-
Thr234/237 is crucial for HCC metastasis through activation 
of Rho kinase II (ROCK2) signaling pathway. To the best 
of our knowledge, this is the first study uncovering how 
NPM phosphorylation (p-NPM-Thr234/237) can influence 
HCC growth and metastasis, and which may be a novel 
phosphorylated substrate for prognosis and therapeutic 
intervention for cancer patients.
RESULTS
Identification of p-NPM-Thr234/237 as critical 
phosphorylation event in HCC metastasis
To understand the molecular mechanism of HCC 
metastasis, we employed primary and corresponding lung-
metastatic counterparts (PLC/PRF/5-PT and PLC/PRF/5-
LM), derived by orthotopic injection of parental PLC/
PRF/5 cells into the liver of the SCID mice [12]. These two 
matched HCC cell lines share the same genetic background 
but differ in their invasive ability. Due to the potential 
involvement of serine/threonine protein kinase in HCC 
metastasis, we have adopted a systemic analysis approach 
to identify corresponding phosphorylated substrate in HCC 
metastasis by profiling these two matched cell lines using 
the CelluSpot™ Serine/Threonine kinase peptide array. 
This glass based array consists of 384 spots in duplicates 
and each spot consists of 15-mer peptide (substrate) 
bound to cellulose (Supplementary Figure 1). The exact 
peptide sequences, corresponding phosphorylation sites 
and kinases are provided by the manufacturer in a excel 
sheet. Upon analysis of the phosphorylation profiles by 
gel documentation system, we identified p-NPM-Thr234/237 
as the most upregulated phosphorylated substrate in PLC/
PRF/5-LM as compared with the PLC/PRF/5-PT cells, with 
4.5-fold overexpression (Figure 1A and Supplementary 
Table 1). NPM phosphorylation at Thr234/237 is the only 
NPM phosphorylation site that spotted on this phospho-
peptide array which is specifically phosphorylated by 
CDK1 (Figure 1B). Western blot analysis confirmed 
elevated p-NPM-Thr234/237 and CDK1 in PLC/PRF/5-LM 
cells using a phospho-NPM (Thr234/237) specific antibody 
(Biolegend) (Figure 1C).
p-NPM-Thr234/237 is associated with HCC 
metastasis
To eliminate any cell type-specific effect, the role 
of p-NPM-Thr234/237 upregulation in HCC metastasis was 
further verified in a pair of metastatic HCC cell lines, 
MHCC-97L and MHCC-97H [13]. Consistently, elevated 
CDK1 and p-NPM-Thr234/237 were also found in the more 
metastatic HCC cell line, MHCC-97H as compared to 
the less metastatic cell line, MHCC-97L, while the total 
NPM level remains unchanged (Figure 2A). In a panel of 
HCC cell lines including Huh7, PLC/PRF/5, SMMC, Bel 
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Figure 1: Identification of p-NPM-Thr234/237 by CelluSpot™ Serine/Threonine kinase peptide array analysis. A. p-NPM-
Thr234/237was found to be 4.5-fold up-regulation in PLC/PRF/5-LM when compared with PLC/PRF/5-PT. B. p-NPM-Thr234/237was found to be 
phosphorylated by CDK1. C. Western blot analysis confirmed up-regulation of p-NPM-Thr234/237 and CDK1 in PLC/PRF/5-LM cells.
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7402, HLE and Hep3B, expression of CDK1 and p-NPM-
Thr234/237 was variable in which Huh7 and Hep3B were 
found to have least expression. There was no obvious 
difference in total NPM expression among these cell lines. 
To further investigate whether this observation is clinically 
relevant, we further examined the role of p-NPM-Thr234/237 
expression in HCC metastasis by examining its expression 
in 28 cases of non-tumorous tissues and their matched 
primary and distinct extra-hepatic metastatic tissues. 
Interestingly, both NPM and p-NPM-Thr234/237 exhibited 
mainly nuclear expression, which were quantitatively 
evaluated using the Aperio ScanScope CS System. 
Immunohistochemistry (IHC) revealed a stepwise increase 
in the expression of NPM-Thr234/237 from non-tumor, 
primary HCC to metastatic HCCs (Figure 2B). p-NPM-
Thr234/237 was found to be preferentially expressed in 
metastatic HCCs when compared with primary HCC in 
terms of abundance and intensity, respectively (p < 0.001, 
student t test) (Figure 2B). For NPM, its expression is 
minimal in non-tumor tissue, but there were no statistical 
difference between primary and metastatic HCCs.
p-NPM-Thr234/237 is critical in HCC migration 
and invasion
To further characterize the functional significance of 
p-NPM-Thr234/237 in HCC, we first subcloned Flag-tagged 
NPM and its phosphorylation site mutant (Thr234/237A) 
into the pCDH vector (System Biosciences) and 
overexpressed the gene in low p-NPM-Thr234/237 
expressing cells (Hep3B and Huh7) using a lentiviral 
transduction system (System Biosciences). Since Hep3B 
and Huh7 expressed significant amount of NPM protein, 
we tried to eliminate the effect of endogenous NPM 
by knocking down its expression by lentiviral based 
knockdown approach. By western blot, NPM protein 
was successfully repressed in Hep3B and Huh7 cells 
(Figure 3A). Similar levels of the Flag-tagged NPM and 
phosphorylation site mutant NPM (Thr234/237A) proteins 
were expressed in Hep3B and Huh7 cells, as determined 
by western blot analysis (Figure 3B). Stable clones were 
also established with the pCDH vector alone to serve 
as a reference for functional comparison. To determine 
the functional significance of p-NPM-Thr234/237 in HCC, 
we first performed proliferation assay to compare the 
growth properties of NPM and its phosphorylation site 
mutant. By BrdU assay, we found significant increase 
in proliferation in Hep3B and Huh7 cells upon NPM 
transfection, while its proliferative effect is only partially 
abolished in Thr234/237A transfectants (Figure 3C). 
This result showed that p-NPM-Thr234/237 is not crucial in 
regulation of HCC cell proliferation Next, we then tested 
potential changes in cell migration and invasion in vitro 
upon transfection of NPM and its Thr234/237A mutant. 
By invasion and migration assays, we found significant 
increase in cell invasion and migration abilities in NPM 
Figure 2: p-NPM-Thr234/237 is upregulated in metastatic HCC. A. CDK1 and its mediated p-NPM-Thr234/237 was up-regulated 
in MHCC-97H when compared with MHCC-97L. In a panel of HCC cell lines, CDK1 and p-NPM-Thr234/237 expression was found to 
be the lowest in Hep3B and Huh7. B. In 28 cases of non-tumorous tissues and their matched primary and distinct metastatic tissues, 
immunohistochemistry revealed a stepwise increase in the expression of p-NPM-Thr234/237 from non-tumor, primary HCC to metastatic 
HCCs and p-NPM-Thr234/237 was found to be preferentially expressed in metastatic HCCs when compared with primary HCC in terms of 
abundance and intensity, respectively (***p < 0.001, student t test). There were no difference between primary and metastatic HCCs for 
NPM expression. Two representative cases (case #9 (adrenal metastasis) and case #16 (spinal metastasis)) were shown.
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Figure 3: p-NPM-Thr234/237 enhanced HCC cell migration and invasion. A. Endogenous NPM was knocked down by using 
lentiviral based knockdown approach. By western blot, NPM protein was successfully repressed in Hep3B and Huh7 cells. B. NPM-wild 
type (NPM WT) and NPM Thr234/237A mutant were efficiently overexpressed in Hep3B and Huh7 cells with a lentiviral-based approach, 
confirmed by protein expression of Flag observed in NPM WT and NPM Thr234/237A transfectants. C. BrdU cell proliferation assay 
demonstrated that NPM wild-type Hep3B and Huh7 cells (NPM WT) had significantly increased cell proliferation rate when compared with 
control (EV); whereas the proliferative effect is partially abolished in NPM Thr234/237A transfectants (*p < 0.05, **p < 0.01 and ***p < 
0.001, student t test). D. Cell Migration and E. invasion assays demonstrated that NPM Thr234/237A mutant transfected Hep3B and Huh7 
cells (NPM Thr234/237A) showed reduced migratory and invasion abilities when compared with respective NPM wild-type transfectants 
(NPM WT) (**p < 0.01 and ***p < 0.001, student t test) (magnification × 10).
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transfectants, while this effect is completely abolished 
in Thr234/237A transfectants. (Figure 3D and 3E). 
Using in vitro scratch assay, we consistently found that 
NPM WT transfected Hep3B and Huh7 cells had greater 
migratory ability and this enhancing effect was abolished 
in Thr234/237 transfectants (Supplementary Figure 2).
CDK1 phosphorylation of NPM at threonine 234/237 
is critical in HCC migration and invasion
Since NPM is phosphorylated on Thr234 and Thr237 
by cyclin-dependent kinase (CDK) 1/cyclinB [11], we 
tested whether knockdown of CDK1 had a role in the 
regulation of p-NPM-Thr234/237 mediated HCC metastasis. 
To examine whether CDK1 is critically involved in p-NPM-
Thr234/237 mediated migration and invasion, we repressed 
expression of CDK1 in high p-NPM-Thr234/237 expressing 
cells (SMMC and Bel 7402). By qPCR and western blot 
analyses, we found successful knockdown of CDK1 
(#C10 and #C11) in SMMC and Bel 7402 cells (Figure 
4A and 4B). Accompanied with the reduction in CDK1 
expression, p-NPM-Thr234/237 was consistently suppressed 
in two shCDK1 clones when compared to NTC control, 
which suggesting that CDK1 is upstream kinase leading 
to NPM phosphorylation at Thr234 and Thr237 (Figure 
4B). After confirming reduction of CDK1 and p-NPM-
Thr234/237expression upon CDK1 knockdown, we examined 
the effect of CDK1 knockdown in cell proliferation. By 
BrdU assay, suppression of CDK1 significantly reduced 
cell proliferation in both SMMC and Bel 7402 cells (Figure 
4C). Next, we examined the effect of CDK1 knockdown in 
cell migration and invasion. Accompanied with reduction 
of p-NPM-Thr234/237 expression of by CDK1 knockdown, 
suppression of CDK1 significantly also reduced the 
migration and invasion of HCC cells (Figure 4D and 4E). In 
addition to the knockdown approach, we further examined 
the effect of CDK1 suppression on HCC cell migration 
and invasion using CDK1 inhibitor (RO-3306, Sigma). 
Upon treatment at 5 and 10 μM for 24 hrs, we consistently 
found decreased number of migrated and invaded cells in 
Bel 7402 and SMMC cells when compared with untreated 
control (Supplementary Figure 3).
p-NPM-Thr234/237 binds ROCK2 and regulates 
LIMK signaling
NPM was found to interact physically with ROCK2 
during centrosome duplication, and NPM phosphorylation 
at Thr199 showed enhanced interaction with ROCK2 [10]. 
In addition, ROCK2 was found to be overexpressed and 
played critical role in HCC invasiveness [14]. To further 
examine whether ROCK2 is one of the major downstream 
effectors of NPM-mediated HCC metastasis, we first 
confirmed the binding between NPM and ROCK2 by 
co-transfecting Flag-tagged NPM plasmid and its mutant 
into Huh7 cells. Immunoprecipitation assays revealed 
a physical interaction between NPM and ROCK2 
(Figure 5A). However, the physical binding is largely 
diminished when Flag-tagged NPM-Thr234/237A was 
transfected. The result indicated that defective Thr234/237 
phosphorylation decreased the binding affinity for ROCK2 
(Figure 5A). Apart from its effect on binding affinity, 
we examined whether p-NPM-Thr234/237 affects ROCK2 
protein expression. However, ROCK2 expression did 
not change upon transfection of Flag-tagged NPM and 
its phosphorylation site mutant (Thr234/237A) (Figure 
5B). Similar result was found in SMMC and Bel 7402 
cells transfected with shCDK1 (Figure 5C). To further 
examine whether this observation is clinically relevant, 
we examined ROCK2 expression in 28 cases of primary 
and their matched distinct extra-hepatic metastatic 
tissues. Consistently, we found no significant difference 
in ROCK2 expression between primary and their matched 
extra-hepatic metastatic tissues (Supplementary Figure 
4). Next, we would like to examine the effect of p-NPM-
Thr234/237 on ROCK2 kinase activity. To evaluate this 
potential effect, we examined the level of phosphorylation 
of LIMK, a substrate of ROCK2, responsible for actin 
polymerization and depolymerization. We found increase 
in LIMK1 (Thr508)/LIMK2 (Thr505) expression in Flag-
tagged NPM cells from Huh7 and Hep3B cells, while 
this effect was abolished in Thr234/237A transfectants 
(Figure 5D). Consistently, knockdown of CDK1 decreased 
expression of LIMK1 (Thr508)/LIMK2 (Thr505) (Figure 
5E). In addition, we examined the effect of p-NPM-
Thr234/237 on expression of MMP-2, and EMT markers 
including E-cadherin, Vimentin and Snail. The result 
revealed that the expression of these markers in NPM-
wild type (NPM WT) and NPM Thr234/237A mutant 
was comparable to control. Similar result was observed 
when CDK1 was knocked down in Bel 7402 and SMMC 
(Supplementary Figure 5). These findings suggest that 
CDK1-mediated phosphorylation of NPM is crucial in 
metastasis through regulation of actin polymerization 
but not EMT and MMP protein. To further investigate 
whether NPM phosphorylation regulates cell motility 
and cancer invasion through modulation of actin stress 
fiber, we examined stress fiber formation and polymerized 
actin in EV, Flag-tagged NPM and its phosphorylation 
site mutant (Thr234/237A) of Hep3B cells. Cytoskeletal 
reorganization exemplified by the formation of stress 
fiber bundling arrays is essential for the contractile 
motion of cancer cells. Using phalloidin staining, we 
found that stress fiber formation was enhanced in NPM 
stable transfectants, while its effect was abolished in its 
phosphorylation site mutant (Thr234/237A) (Figure 5F).
DISCUSSION
Several chromosomal alterations, such as 13q 
[15] and amplification of 1q12-q22 [16, 17], have 
been reported in HCC metastasis. The advent of cDNA 
Oncotarget43489www.impactjournals.com/oncotarget
Figure 4: CDK1, upstream kinase of NPM, enhanced HCC cell migration and invasion. A. CDK1 was efficiently knocked 
down (C10 and C11) in Bel 7402 and SMMC with a lentiviral-based approach, confirmed by qPCR. B. Knockdown of CDK1 reduced 
NPM phosphorylation but not the total NPM when compared with NTC. C. BrdU cell proliferation assay demonstrated that Knockdown 
of CDK1 in Bel 7402 and SMMC cells (shCDK1-C10 and shCDK1-C11) significantly reduced cell proliferation rate with compared with 
control (NTC) (*p < 0.05, student t test). D. Cell migration and E. invasion assays demonstrated the number of migrated and invaded cells 
was significantly reduced in shCDK1-transfected Bel 7402 and SMMC cells (shCDK1-C10 and shCDK-C11) when compared with control 
(NTC) (*p < 0.05, **p < 0.01, ***p < 0.001, student t test) (magnification × 10).
Oncotarget43490www.impactjournals.com/oncotarget
microarray technology allows the use of genome-wide 
expression profiling to identify metastasis-associated 
genes [18]. It is now generally recognized that mRNA 
microarray results should be considered preliminary data 
that require independent follow-up validation because 
proteins, rather than transcripts, are the major effectors 
of cellular function [19]. Therefore, the identification 
of proteins critical for metastatic process by proteomic 
profiling has become a new avenue to study HCC 
metastasis. However, proteomic analyses are complicated 
by post-translational modifications to proteins. One such 
modification, protein phosphorylation, plays a significant 
role in many physiological processes including HCC 
metastasis [20]. Using a pair of primary and a matched 
metastatic counterpart (PLC/PRF-PT and PLC/PRF/5-
LM), we have compared their phosphorylation profiles 
Figure 5: p-NPM-Thr234/237 regulated metastasis through Rho-ROCK-LIM kinase pathway. A. Immunoprecipitation assays 
revealed a physical interaction between NPM and ROCK2. B. The protein expression of ROCK2 in NPM-wild type (NPM WT) and 
NPM Thr234/237A mutant was comparable to control. C. Knockdown of CDK1 did not change the protein expression of ROCK2 when 
compared to NTC. D. NPM Thr234/237A mutate reduced phosphorylation of LIM kinase (LIMK), a substrate of ROCK2, in Hep3B and 
Huh7 transfected cells. E. Similar results were observed when CDK1 was knocked down in Bel 7402 and SMMC cells. F. NPM WT 
transfectants exhibited increased stress fiber network. Stress fibers (polymerized actin) and actin filaments were demonstrated by phalloidin 
(red), while NPM Thr234/237A mutant exhibited loss of stress fibers, when compared with NPM WT. (magnification × 63).
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and identified p-NPM-Thr234/237 to be upregulated in PLC/
PRF/5-LM. Such observation was also observed in another 
pair of primary and a matched metastatic counterpart 
(MHCC-97L and MHCC-97H), suggesting p-NPM-
Thr234/237 upregulation in metastatic HCC cell line is not 
cell line specific.
The physiological function of NPM in tumorigenesis 
remains controversial. NPM mutant mice have aberrant 
oncogenesis, which leads to unrestricted genomic 
instability [4]. In contrast, mutations in NPM in acute 
myelogenous leukemia disrupt the NPM nucleolar-
localization signal, causing accumulation of NPM in 
the cytoplasm [21]. Moreover, NPM may contribute 
to oncogenesis by activating the oncogenic potential of 
a fused protein partner, such as RARα [22]. In HCC, 
NPM overexpression was found to be associated with 
pathological grading [22], metastatic behavior [23, 24] 
and drug resistance [23, 24]. Despite all these findings, 
how phosphorylation events of NPM affects the tumor 
behavior has not been addressed so far. Our results 
suggested that p-NPM-Thr234/237 is critical in invasion and 
migration of HCC cells. Since NPM is phosphorylated 
on Thr234 and Thr237 by cyclin-dependent kinase 
(CDK) 1 [11], we tested whether knockdown of CDK1 
had a role in the regulation of p-NPM-Thr234/237 mediated 
HCC metastasis. Similar to the effect to the Thr234/237A 
transfectants, knockdown of CDK1 also suppressed HCC 
cell proliferation, migration, and invasion. Our result 
is consistent to previous report showing that CDK1 is 
overexpressed in HCC and its expression is correlated with 
aggressive tumor behavior and recurrence of HCC [25]. In 
addition, CDK1 was reported to be a useful biomarker for 
HCC to distinguish from non-tumor liver [26]. Recently, 
CDK1 is an attractive therapeutic target for suppression of 
HCC metastasis by a garlic derivative (SAC) [27].
NPM was found to interact physically with ROCK2 
during centrosome duplication, and NPM phosphorylation 
at Thr199 showed enhanced interaction with ROCK2 
[10]. ROCK2 was found to be overexpressed and played 
critical role in HCC invasiveness through regulation of 
actin polymerization [14], MMP2 degradation [28] and 
EMT [29]. To further examine whether ROCK2 is one of 
the major downstream effectors of NPM-mediated HCC 
metastasis, we first confirmed the binding between NPM 
and ROCK2 by transfecting flag-tagged NPM plasmids into 
Huh7 cells. To explore whether p-NPM-Thr234/237 is critical 
for NPM/ROCK2 complex formation, we performed 
immunoprecipitation after transfection of Flag-tagged 
Thr234/237A into Huh7 cells. The result indicated that 
defective in Thr234/237 phosphorylation decreased the 
binding affinity for ROCK2, when compared with the wild-
type NPM. By western blot analysis, we found that such 
alteration of binding between NPM and ROCK2 did not 
affect the protein expression of ROCK2. Instead, it affected 
the transcriptional activity of ROCK2, which resulted in 
change in expression of its downstream transcriptional 
target LIMK1/LIMK2. ROCK2/LIMK/cofilin pathway 
was previously reported to maintain actin stress fibers in 
fibroblasts [30]. Consistently, we found p-NPM-Thr234/237 
regulates phosphorylation of LIMK, which is accompanied 
with increase in stress fiber formation.
In conclusion, we found that CDK1 mediated 
phosphorylation of p-NPM-Thr234/237 may play a role in 
growth and metastasis of HCC cells through interaction 
with a novel metastatic gene, ROCK2. Thus, targeting 
of CDK1/p-NPM/ROCK2 signaling pathway may be a 
potential therapeutic strategy for treatment of HCC patients.
MATERIALS AND METHODS
Cell lines
The human HCC cell lines Huh7, HLE, PLC/PRF/5 
(Japanese Cancer Research Bank, Japan), Bel 7402, 
SMMC-7721, (SIBS, Chinese Academy of Sciences), 
Hep3B, MHCC-97L, MHCC-97H, (Liver Cancer Institute, 
Fudan University, China) were grown in Dubecco’s 
modified Eagle minimal high glucose essential medium 
(DMEM-HG) (Gibco-BRL) supplemented with 10% fetal 
bovine serum (FBS) (Gibco-BRL) and 1% penicillin and 
streptomycin (Gibco-BRL).
Human HCC samples
Human primary HCCs and their metastatic 
counterparts, and corresponding non-tumorous liver 
samples in the cohort of 28 primary HCCs were obtained 
from patients with liver resection between 1993 and 2007 
at Queen Mary Hospital, Hong Kong and randomly selected 
for the present study. The metastatic sites of these 28 HCC 
cases was shown in Table 1. All specimens collected were 
either snap-frozen in liquid nitrogen and stored at −80°C, 
or fixed in 10% formalin for paraffin embedding. Frozen 
sections from tumorous and non-tumorous liver samples 
were cut and stained for histological examination to ensure 
homogenous cell population of tissues. Use of human 
specimens was approved by the institutional review board 
of the University of Hong Kong/Hospital Authority Hong 
Kong West Cluster.
Plasmids and cloning
The full-length human cDNA (HA-NPM) and its 
NPM mutants containing threonine to alanine mutations 
at Thr234 and Thr237 (HA-NPM-Thr234/237) were a 
gift from Dr. Paul Shapiro (University of Maryland, 
USA). Flag-tagged -NPM and -NPM-Thr234/237A 
were further subcloned to lentivial based pCDH vector 
(System Biosciences). The sequence of NPM and NPM-
Thr234/237 were verified by DNA sequencing.
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CelluSpot™ serine/threonine kinase I peptide 
array
CelluSpots™ Serine/Threonine kinase I peptide array 
was purchased from Intavis AG (Köln, Germany). Each slide 
contains 384 evaluated kinase substrates as well as consensus 
sequences for serine/threonine kinases spotted in duplicate.
Binding of protein lysate to peptide array
Protein lysate of PLC/PRF/5-PT and PLC/PRF/5-LM 
was prepared by solubilizing their corresponding cell pellets in 
cell lysis buffer following by sonication. After determination 
of the total protein concentration, 300 μg/ml of protein 
lysate was added to cell lysate reaction mixture containing 
10 μM ATP and 300 μCi/mL[γ-33P]ATP and incubated 
with incubation chamber for 2 hours. After incubation, the 
slide was washed two times 5 minutes with washing buffer, 
followed by three washing steps in dH
2
O for 5 minutes at 
room temperature. The dried slide was imaged on x-ray film 
for different time periods. The intensity of phosphorylation 
profiles was evaluated by gel documentation system.
Lentiviral-based transfection into HCC cells
For suppression of NPM in HCC cells, lentiviral 
particles (DFCI-Broad RNAi Consortium, Boston) 
expressing shRNAs against human NPM were used to 
Table 1: Sites of extrahepatic metastasis in 28 primary HCC samples
Case number Sites of extrahepatic metastasis
1 Intraperitoneal tissue
2 Diaphragm
3 Main portal vein thrombus
4 Lung
5 Adrenal
6 Bone
7 Brain
8 Peritoneum
9 Adrenal
10 Lung
12 Spleen
13 Colon
16 Spinal
17 Abdominal wall
20 Lymph node
21 Thoracic cavity
22 Retro-caval lymph node
23 Scapular nodule
24 Colon
25 Lung
26 Lymph node
27 Diaphragm
28 Spleen
29 Bone
30 Retro-pancreatic tissue
31 Brain
33 Omentum
36 Lung
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downregulate NPM mRNA (CCGGGCCAAGAATGTGT 
TGTCCAAACTCGAGTT TGGACAACACATTCTTGG 
CTTTTTG). For suppression of CDK1 in HCC cells, lentiviral 
particles (DFCI-Broad RNAi Consortium, Boston) expressing 
shRNAs against human CDK1 were used to downregulate 
CDK1 mRNA (clone C10:CCGGGCTGTACTTCGTCTTCT
AATTCTCGAGAATTAGAAGACGAAGTACAGCTTTTT; 
clone C11:CCGGGTGGAATCTTTACAGGACTATCTCGA
GATAGTCCTGTAAAGATTCCACTTTTT). For functional 
characterization of NPM and its phosphorylation mutant, 
we have ectopically transfected flag-tagged NPM or its 
phosphorylation site mutants (Thr234/237A) by the lentiviral 
based approach provided by System Biosciences. Transduced 
cells were selected with 2 μg/mL puromycin.
Proliferation assay
Cells at the density of 5 × 103 were seeded in 96-
well cell culture plates and allowed to adhere overnight. At 
the indicated time points, cell proliferation was measured 
by using BrdU proliferation assay kit (Roche Diagnostics 
Corporation, Indianapolis, Indiana, USA) according to 
manufacturer’s instructions. The experiment was carried 
out thrice independently.
Migration and invasion assays
Cell migration was investigated using transwell 
inserts with 6.5 mm polucarboate membranes of 8.0 μm 
pore size (Corning Inc., NY, USA). Cells (1*e5) in serum-
free medium were seeded onto the upper chamber of the 
transwell and the culture medium containing 10% FBS was 
added into the lower chamber serving as chemoattractant. 
Cells were incubated for 24 hr to allow for migration 
through the membrane. Migrated cells were then fixed 
by 2% paraformaldehyde and stained with crystal violet. 
Stained cells were captured randomly for three fields under 
a light microscope and ells were counted. The experiments 
were repeated independently three times.
The cell invasion assay was performed with self-
coated Matrigel (BD Biosciences, San Jose, CA) on the 
upper surface of a transwell chamber. The invasive cells 
that had invaded through the extracellular matrix layer 
to the lower surface of the membrane were fixed with 
2% paraformaldehyde and stained with crystal violet. 
Photographs of three randomly selected fields of the 
fixed cells were captured and cells were counted. The 
experiments were repeated independently three times.
In vitro scratch assay
Cells were seeded in 12-well plates and culture till 
confluent. P20 pipette tip was used to create a scratch 
of the cell monolayer. The plate was washed once and 
replaced with the desired medium. Images were captured 
(magnification × 4) at 0 hr and 24 hr.
Quantitative PCR (qPCR) analysis
Total RNA was isolated using Trizol reagent 
according to the manufacturer’s protocol (Invitrogen, 
Carlsbad, CA). Complementary DNA (cDNA) was 
synthesized using a GeneAmp® Gold RNA PCR Kit 
(Applied Biosystems, Foster City, CA) according to the 
manufacturer’s instructions and then subjected to PCR with 
a SYBR Green PCR kit. The primer sequence for CDK1 
is (Forward: 5′-CTGGGGTCAGCTCGTTACTC-3′; 
Reverse: 5′-TCCACTTCTGGCCACACTTC-3)′. The 
amplification protocol consisted of incubations at 94°C for 
15 seconds, 63°C for 30 seconds, and 72°C for 60 seconds. 
Incorporation of the SYBR Green dye into PCR products 
was monitored in real time with an ABI 7900HT Sequence 
Detection System and SDS 1.9.1 software (Applied 
Biosystems) and subsequently analyzed using RQ Manager 
1.2 software (Applied Biosystems), thereby allowing the 
threshold cycle (C
T
) at which exponential amplification of 
the products began to be determined. The amount of target 
cDNA was calculated relative to that of β-actin cDNA.
Western blot analysis
Western blots were developed using an ECL 
Plus kit (Amersham Biosciences, Piscataway, NJ). The 
primary antibodies included rabbit polyclonal anti-
CDK1/CDC2 (Proteintech), rabbit monoclonal anti-
LIMK2 (Cell signaling technology, Danvers, MA, 
USA), rabbit polyclonal anti-phospho-LIMK1 (Thr508) 
/ LIMK2 (Thr505) (Cell signaling technology, Danvers, 
MA, USA), mouse monoclonal anti-NPM (Invitrogen 
Corporation, CA), rabbit polyclonal anti-phosphorylated 
Thr234/Thr237 NPM (BioLegend, CA), rabbit polyclonal 
anti-ROCK2 (Santa Cruz Biotechnology, CA), mouse 
polyclonal anti-Actin (Sigma-Aldrich, St. Louis, MO, 
USA). After washing, the membrane was incubated with 
horseradish peroxidase-conjugated anti-mouse or rabbit 
antibody (Amersham) and then visualized with enhanced 
chemiluminescence plus according to the manufacturer’s 
protocol.
Immunoprecipitation
Cells transiently transfected with different 
constructs were lysed with RIPA buffer. The lysate 
was then precleared with 30 μl of protein G agarose 
(Amersham, Piscataway, NJ) and normal mouse IgG for 
1 h at 4°C. The precleared lysate was then incubated 
with anti-Flag (Sigma-Aldrich, St. Louis, MO, USA) 
antibody for 1 h at 4°C and then with protein G agarose 
for another hour at 4°C. The agarose was then washed 
three times with 1 ml of RIPA buffer, boiled and then 
loaded onto SDS-polyacrylamide gel for electrophoresis 
and Western blotting analysis with the procedure 
described above.
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Immunohistochemical staining
For paraffin-embedded tissues, sections were 
deparaffinized in xylene and rehydrated in graded 
alcohols and distilled water. Slides were processed 
for antigen retrieval by a standard microwave 
heating technique. Specimens were incubated with 
NPM (B0556, Sigma), p-NPM-Thr234/237 (619102, 
Biolegend) and ROCK2 (21645-1-AP, Proteintech) in 
a dilution of 1:100. Subsequent immunodetection was 
performed using the standard rapid EnVision technique. 
The reaction was then developed with the DAKO 
Liquid DAB_Substrate-Chromogen System (DAKO, 
Carpentaria, CA). Sections were counterstained with 
Mayer’s hematoxylin. Stained slides were imaged on an 
Aperio Scanscope® CS imager (Vista, CA), generating 
0.43 μm/pixel whole slide images. These images were 
compiled, and NPM and p-NPM-Thr234/237 expression 
in terms of intensity and abundance were quantitated 
using the Aperio Spectrum® software with a pixel count 
algorithm.
Immunofluorescence microscopy
Cells were seeded onto coverslips and incubated 
overnight at 37°C in a CO2 incubator, then were 
fixed with 4% paraformaldehyde in phosphate-
buffered saline (PBS) and permeabilized with 0.1% 
Triton X-100 in PBS. Fixed cells were incubated with 
1:5000 tetramethylrhodamine-conjugated phalloidin 
(Sigma-Aldrich, St. Louis, MO, USA). Cells were 
counterstained with 4′,6-diamidino-2-phenylindole 
(DAPI) (Calbiochem, San Diego, CA) and mounted with 
Vectashield antifade mountant (Vector Laboratories, 
Burlingame, CA). Images were captured under × 63 
magnification by a fluorescence microscope (Carl Zeiss 
LSM 510 Meta/Axiocam).
Statistical analysis
All statistical analyses were performed using the 
statistical software SPSS 17 for Windows (SPSS Inc., 
Chicago, IL). Student’s t was used for continuous data 
wherever appropriate. p values less than 0.05 were 
considered significant.
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